ClinIntel Report issue

For profit Phase 3 Phase 4
Founded: Crawley United Kingdom (2009)
Status: Acquired by Parexel (2014)

Organization Overview

First Clinical Trial
2013
NCT02009410
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree